Department of Neurosurgery, Helsinki University Central Hospital, Finland.
Stroke. 2012 Aug;43(8):2091-6. doi: 10.1161/STROKEAHA.112.650077. Epub 2012 Jun 12.
Knowledge of the long-term excess mortality in pediatric aneurysm patients is lacking. The aim of this study was to assess the long-term excess mortality of 102 pediatric patients with cerebral aneurysm treated at the department of neurosurgery at Helsinki University Central Hospital between 1937 and 2009.
Patients were followed from diagnosis until death or the end of the year 2010. Relative survival ratio provided the measure of excess mortality in these patients compared with mortality of the general Finnish population matched by age, sex, and calendar time.
A majority of the patients (n=89) presented with subarachnoid hemorrhage. Aneurysms (n=118) were treated operatively (n=79), endovascularly (n=1), or conservatively (n=36). The mean follow-up time was 26.8 years (range, 0-55.6 years). By the end of follow-up, 34 of the 102 patients had died; 26 of these deaths (76%) were aneurysm-related. There was overall excess mortality of 10% (cumulative relative survival ratio, 0.90; 95% CI, 0.80-0.96) and 19% (cumulative relative survival ratio, 0.81; 95% CI, 0.66-0.91) at 20 and 40 years after the diagnosis among the 1-year subarachnoid hemorrhage survivors, respectively. The excess mortality was particularly high in boys. There was no long-term excess mortality among patients with unruptured aneurysms. Aneurysm-related deaths included rebleedings from open or partially occluded aneurysms, epileptic seizures, de novo and recurrent aneurysms, or sequelae of subarachnoid hemorrhage.
There is long-term excess mortality in pediatric patients with aneurysm even decades after successful treatment of a ruptured aneurysm, especially among boys. The excess mortality is mainly aneurysm-related.
缺乏儿科动脉瘤患者长期超额死亡率的相关知识。本研究旨在评估赫尔辛基大学中心医院神经外科自 1937 年至 2009 年期间治疗的 102 例脑动脉瘤儿科患者的长期超额死亡率。
患者自诊断起随访至死亡或 2010 年末。相对生存率为这些患者与按年龄、性别和时间匹配的芬兰一般人群相比的超额死亡率的衡量标准。
大多数患者(n=89)表现为蛛网膜下腔出血。共治疗了 118 个动脉瘤(n=118),其中 79 个采用手术治疗(n=79),1 个采用血管内治疗(n=1),36 个采用保守治疗(n=36)。平均随访时间为 26.8 年(范围,0-55.6 年)。随访结束时,102 例患者中有 34 例死亡;其中 26 例(76%)死亡与动脉瘤相关。总体超额死亡率为 10%(累积相对生存率为 0.90;95%CI,0.80-0.96),1 年后诊断为蛛网膜下腔出血的幸存者中分别为 19%(累积相对生存率为 0.81;95%CI,0.66-0.91)和 40 年。男孩的超额死亡率特别高。未破裂动脉瘤患者无长期超额死亡率。与动脉瘤相关的死亡包括开颅或部分闭塞动脉瘤的再出血、癫痫发作、新发和复发性动脉瘤或蛛网膜下腔出血的后遗症。
即使在成功治疗破裂动脉瘤后的几十年,儿科动脉瘤患者仍存在长期超额死亡率,尤其是男孩。超额死亡率主要与动脉瘤相关。